TREATMENT OF NON INFECTIOUS UVEITIS THROUGH EYE INJECTION

Not yet recruiting

• Conditions: Unspecified chorioretinal inflammation,

• Registration Number: CTRI/2023/03/050981
• Lead Sponsor: GSVM MEDICAL COLLEGE

Brief Summary

This is Randomised prospective study , to assess the role of suprachoroidal injection of Triamcinolone in patients of non- infectious anterior, non-infectious intermediate and non-infectious posterior uveitis. Primary outcome will be BCVA  improvement in 3-15 days.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-03-17
• Study Start: 2023-03-27

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• 1. Newly diagnosed patients of non-infectious anterior uveitis.
• (2) Newly diagnosed patients of non-infectious intermediate uveitis.
• (3) Newly diagnosed patients of non-infectious posterior uveitis.

Exclusion Criteria

• (1) Patients not willing to participate or ready for follow up.
• (2) Patients with uncontrolled blood sugar.
• (3) Patients with any ocular disease other than uveitis.
• (4) Patients contraindicated for suprachoroidal injection eg.
• thinned sclera, scleritis, staphylococcus.
• (5) Patients of hypersensitivity for Triamcinolone.
• (6) Patients diagnosed of any other posterior segment pathologies.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1) BCVA	3 days after injection
2) Slit lamp examination	3 days after injection
3) Intra ocular pressure	3 days after injection

Secondary Outcome Measures

Name	Time	Method
BCVA	Slit lamp examination

Trial Locations

Locations (1)

GANESH SHANKAR VIDYARTHI MEDICAL COLLEGE; 🇮🇳 Nagar, UTTAR PRADESH, India

GANESH SHANKAR VIDYARTHI MEDICAL COLLEGE

🇮🇳Nagar, UTTAR PRADESH, India

Ritu

Principal investigator

8887578040

dr.ritukumar05@gmail.com